U.S. Vaginal Atrophy Treatment Market Size, Share & Industry Analysis, By Therapy Type (Drug Therapies {Estrogen Based [Imvexxy, Premarin, and Others], Non-Estrogen Based [Intrarosa, Osphena, and Others]}, and Non-Drug Therapies {Light Therapy, Laser, and Others}), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Store & Pharmacies, and Online Channels), and Country Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI109727

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 4.1% from 2024-2032
Unit	Value (USD Billion)
Segmentation	By Therapy Type Drug Therapies Estrogen Based Imvexxy Premarin Others Non-Estrogen Based Intrarosa Osphena Others Non-Drug Therapies Light Therapy Laser Others
	By Route of Administration Oral Parenteral Topical
	By Distribution Channel Hospital Pharmacies Retail Stores & Pharmacies Online Channels